Founder and CEO

More than 20 years of experience in biotechnology drug R & D management. As the first person in charge, he successfully presided over the R & D of recombinant hirudin, PTH (1-84) (Class 1 new drug), cpg2 (Class 1 new drug), KR-1 and other biological new drugs.

It has undertaken national key projects such as major new drug creation in the eleventh five year plan, major special projects of the national development and Reform Commission and the innovation fund of the Ministry of science and technology.

Good at building R & D team and mechanism construction.

He once worked in the top ten large pharmaceutical enterprises in China and was in charge of biopharmaceutical R & D.

Familiar with the development law and project cooperation mode of biopharmaceutical industry at home and abroad, and has established good cooperative relations with many large domestic pharmaceutical enterprises.


Specialty: Kerun biology has a professional R & D expert team with innovative spirit, and has the product development ability from project selection, upstream design, process amplification, quality control to registration and application, clinical research and other systems. The key posts have more than 10 years of experience in the new drug R & D industry.

Special research: full of innovative spirit and dare to be the first. It has independent advantages and R & D characteristics in genetic engineering drug design, process optimization, pilot production, quality research and so on.

Focus: unity and cooperation, high efficiency and high energy. Under the circumstances of limited funds and fierce industry competition, we still stick to our original intention, forge ahead, and always focus on deep cultivation and meticulous work in the field of protein drugs.

Scientific orientation and pursuit of excellence. In order to ensure the high quality of R & D, Kerun biology specially employs a number of senior experts in the biopharmaceutical industry at home and abroad as consultants to provide all-round support for the company's drug R & D.